Skip to content

An Exploratory Study Investigating Human Skin Reaction to Output

An Exploratory Study Investigating Human Skin Reaction to Output

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02351791
Enrollment
22
Registered
2015-01-30
Start date
2015-02-28
Completion date
2015-03-31
Last updated
2023-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy

Brief summary

The primary purpose of the study is to investigate the impact that feces mixtures have on the peristomal skin when using a standard adhesive.

Detailed description

Six types of patches are tested: Patch 1: Standard adhesive with own feces Patch 2: Standard adhesive with own feces mixture Patch 3: Standard adhesive with simulated feces Patch 4: Standard adhesive with simulated feces mixture Patch 5: Standard adhesive with buffer (control) Patch 6: Standard adhesive with buffer feces mixture (control) Each subject is randomized to one of two arms testing three patches on the peristomal skin (patch 1, 3 and 5 or patch 2, 4 and 6). Furthermore, within each arm an attempt will be made to randomize each of the three patches on the peristomal skin to one of three locations surrounding the stoma (upper left, upper right, lower). On the healthy contralateral abdominal skin the subjects test all six patches. A run in period with 2 subjects (healthy volunteers) was conducted to clarify the length of the test period. They were exposed to 4 patches (patch 3-6) on healthy abdominal skin which was removed at 2 different time slots. Based on the results the test period was established

Interventions

OTHERPatch 1

Patch 1:standard adhesive with own feces in sleeve

OTHERPatch 2

Patch 2:standard adhesive with own feces mixture in sleeve

OTHERPatch 3

Patch 3: standard adhesive with simulated feces in sleeve

OTHERPatch 4

Patch 4:standard adhesive with simulated feces mixture in sleeve

OTHERPatch 5

Patch 5:standard adhesive with buffer in sleeve

OTHERPatch 6

Patch 6:standard adhesive with buffer mixture in sleeve

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have given written informed consent * Be at least 18 years of age and have full legal capacity * Have had an ileostomy for more than one year * Have normal to slightly red skin on the area used in the evaluation * Has an ileostomy with a diameter up to (≤) 35 mm * Have a peristomal area accessible for applied patches (assessed by investigator)

Exclusion criteria

* Currently receiving or have within the past 2 months received radio- and/or chemotherapy * Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment * Are pregnant or breastfeeding * Having dermatological problems in the peristomal- or abdominal area (assessed by investigator) * Participating in other interventional clinical investigations or have previously participated in this investigation

Design outcomes

Primary

MeasureTime frameDescription
Trans Epidermal Water Loss After Test of Patches.Approximately 7-10 hoursTrans Epidermal Water Loss is a standardized non-invasive method for describing the barrier function of the skin. Damage to the skin surface (stratum corneum) will lower the barrier of the skin and thereby increase water loss. This can be used as a measure for the damaging effect of the adhesives to the skin. Trans Epidermal Water Loss is measured by applying a probe to the skin surface and is assessed nine times for each patch after applying the patch: three repeated measurements of the skin covered by the center of the patch (Center), as well as three repeated measurements of the skin covered by the adhesive (Under adhesive).

Countries

Denmark

Participant flow

Participants by arm

ArmCount
Peristomal Patches: Patch 1, 3 and 5
Patch 1, Patch 3 and Patch 5 applied on peristomal skin. Patch 1 - Patch 6 applied on healthy abdominal skin Measurements of skin at three locations of each patch: Center and under adhesive. Patch 1: Patch 1:standard adhesive with own feces in sleeve Patch 2: Patch 2:standard adhesive with own feces mixture in sleeve Patch 3: Patch 3: standard adhesive with simulated feces in sleeve Patch 4: Patch 4:standard adhesive with simulated feces mixture in sleeve Patch 5: Patch 5:standard adhesive with buffer in sleeve Patch 6: Patch 6:standard adhesive with buffer mixture in sleeve
12
Peristomal Patches: Patch 2, 4 and 6
Patch 2, Patch 4 and Patch 6 applied on peristomal skin. Patch 1- Patch 6 applied on healthy abdominal skin Measurements of skin at three locations of each patch: Center and under adhesive. Patch 1: Patch 1:standard adhesive with own feces in sleeve Patch 2: Patch 2:standard adhesive with own feces mixture in sleeve Patch 3: Patch 3: standard adhesive with simulated feces in sleeve Patch 4: Patch 4:standard adhesive with simulated feces mixture in sleeve Patch 5: Patch 5:standard adhesive with buffer in sleeve Patch 6: Patch 6:standard adhesive with buffer mixture in sleeve
10
Total22

Baseline characteristics

CharacteristicPeristomal Patches: Patch 1, 3 and 5Peristomal Patches: Patch 2, 4 and 6Total
Age, Continuous63.1 years
STANDARD_DEVIATION 12.9
64.1 years
STANDARD_DEVIATION 5.2
63.5 years
STANDARD_DEVIATION 10
Sex: Female, Male
Female
2 Participants3 Participants5 Participants
Sex: Female, Male
Male
10 Participants7 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 24
serious
Total, serious adverse events
0 / 24

Outcome results

Primary

Trans Epidermal Water Loss After Test of Patches.

Trans Epidermal Water Loss is a standardized non-invasive method for describing the barrier function of the skin. Damage to the skin surface (stratum corneum) will lower the barrier of the skin and thereby increase water loss. This can be used as a measure for the damaging effect of the adhesives to the skin. Trans Epidermal Water Loss is measured by applying a probe to the skin surface and is assessed nine times for each patch after applying the patch: three repeated measurements of the skin covered by the center of the patch (Center), as well as three repeated measurements of the skin covered by the adhesive (Under adhesive).

Time frame: Approximately 7-10 hours

Population: three repeated measurements per participant were performed and used in analysis e.g. 12 participants have 3x12=36 units analysed.

ArmMeasureValue (MEAN)Dispersion
Peristomal Skin Patch 1 CenterTrans Epidermal Water Loss After Test of Patches.45.8 g/m^2/hStandard Deviation 29.3
Peristomal Skin Patch 2 CenterTrans Epidermal Water Loss After Test of Patches.22.9 g/m^2/hStandard Deviation 16.4
Peristomal Skin Patch 3 CenterTrans Epidermal Water Loss After Test of Patches.36.8 g/m^2/hStandard Deviation 21.7
Peristomal Skin Patch 4 CenterTrans Epidermal Water Loss After Test of Patches.19.6 g/m^2/hStandard Deviation 11.6
Peristomal Skin Patch 5 CenterTrans Epidermal Water Loss After Test of Patches.15.7 g/m^2/hStandard Deviation 6.9
Peristomal Skin Patch 6 CenterTrans Epidermal Water Loss After Test of Patches.13.3 g/m^2/hStandard Deviation 7.1
Abdominal Skin Patch 1 CenterTrans Epidermal Water Loss After Test of Patches.30.1 g/m^2/hStandard Deviation 25.5
Abdominal Skin Patch 2 CenterTrans Epidermal Water Loss After Test of Patches.22.7 g/m^2/hStandard Deviation 23.1
Abdominal Skin Patch 3 CenterTrans Epidermal Water Loss After Test of Patches.31.5 g/m^2/hStandard Deviation 27.7
Abdominal Skin Patch 4 CenterTrans Epidermal Water Loss After Test of Patches.14.5 g/m^2/hStandard Deviation 12.7
Abdominal Skin Patch 5 CenterTrans Epidermal Water Loss After Test of Patches.13.2 g/m^2/hStandard Deviation 8.7
Abdominal Skin Patch 6 CenterTrans Epidermal Water Loss After Test of Patches.12.2 g/m^2/hStandard Deviation 7.6
Peristomal Skin Patch 1 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.19.5 g/m^2/hStandard Deviation 16.4
Peristomal Skin Patch 2 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.12.3 g/m^2/hStandard Deviation 8.7
Peristomal Skin Patch 3 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.14.5 g/m^2/hStandard Deviation 11.7
Peristomal Skin Patch 4 Under PatchTrans Epidermal Water Loss After Test of Patches.14.7 g/m^2/hStandard Deviation 7.6
Peristomal Skin Patch 5 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.13.8 g/m^2/hStandard Deviation 8.8
Peristomal Skin Patch 6 Under PatchTrans Epidermal Water Loss After Test of Patches.15.1 g/m^2/hStandard Deviation 8.1
Abdominal Skin Patch 1 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.19.0 g/m^2/hStandard Deviation 12.7
Abdominal Skin Patch 2 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.19.9 g/m^2/hStandard Deviation 16.5
Abdominal Skin Patch 3 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.18.7 g/m^2/hStandard Deviation 15.4
Abdominal Skin Patch 4 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.17.3 g/m^2/hStandard Deviation 15.1
Abdominal Skin Patch 5 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.15.3 g/m^2/hStandard Deviation 11.1
Abdominal Skin Patch 6 Under AdhesiveTrans Epidermal Water Loss After Test of Patches.15.7 g/m^2/hStandard Deviation 10.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026